Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.73 |
| ▸ | SRC | P12931 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11315838 | 0.85 | CYP2D6 (1.00) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL7815004 | 0.85 | CYP2D6 (1.00) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL659768 | 0.85 | CYP2D6 (1.00) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL7824857 | 0.85 | CYP2D6 (1.00) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL12870188 | 0.84 | CYP2D6 (0.56) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL27818755 | 0.82 | CYP2D6 (0.94) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL11022387 | 0.82 | CYP2D6 (0.54) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL11369030 | 0.79 | CYP2D6 (0.77) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL29054565 | 0.79 | CYP2D6 (0.61) | CYP2D6SRCLMNAMAPK1KMT2A | |
| SCHEMBL21939337 | 0.78 | CYP2D6 (0.76) | CYP2D6SRCLMNAMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116606206-A | Preparation process of picoxystrobin intermediate methyl o-chloromethyl phenylacetate | 河北诚信集团有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116606206-A | Preparation process of picoxystrobin intermediate methyl o-chloromethyl phenylacetate | 河北诚信集团有限公司 | 2023-08-18 | — | — | CN | disclosed |
| EP-1072580-B1 | PROCESS FOR PRODUCING CHLOROMETHYLPHENYLACETIC ACID | IHARA CHEMICAL IND CO (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-7491834-B2 | Chemical process | SYNGENTA CROP PROTECTION, INC. (US) | 2009-02-17 | — | — | US | disclosed |
| US-20060163159-A1 | Chemical process | SYNGENTA CROP PROTECTION, INC. | 2006-07-27 | — | — | US | disclosed |
| EP-1506184-A2 | PROCESS FOR THE PREPARATION OF 3-ISOCHROMANONE | Syngenta Limited (GB) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003095442-A2 | PROCESS FOR THE PREPARATION OF 3-ISOCHROMANONE | SYNGENTA LIMITED (GB) | 2003-11-20 | — | — | WO | disclosed |
| US-6414186-B1 | REACTING METHYLPHENYLACETIC ACID WITH CHLORINE GAS, IN INERT SOLVENT, UNDER IRRADIATION WITH LIGHT OR IN PRESENCE OF RADICAL INITIATOR | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2002-07-02 | — | — | US | disclosed |
| EP-1072580-A1 | PROCESS FOR PRODUCING CHLOROMETHYLPHENYLACETIC ACID | Ihara Nikkei Chemical Industry Co., Ltd. (JP) | 2001-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060163159-A1 | Chemical process | HAO2, OGDH, TST | CYP2D6 297/4885SRC 262/4885LMNA 4573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.